Clinical Trial Update: A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating intraprostatic injection of 2-hydroxyflutamide (Liproca Depot) in men with localized prostate cancer has completed; the snippet prese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Liproca Depot (2-hydroxyflutamide)

Snippet

Sponsor: Lidds AB | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED